Get the Stockscreener App
349.04
0.96%
-3.37
After Hours:
340.00
-9.04
-2.59%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Waters Corp stock is traded at $349.04, with a volume of 429.41K.
It is down -0.96% in the last 24 hours and down -0.06% over the past month.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions.
See More
Previous Close:
$352.41
Open:
$352.19
24h Volume:
429.41K
Relative Volume:
0.82
Market Cap:
$20.82B
Revenue:
$2.91B
Net Income/Loss:
$622.64M
P/E Ratio:
33.31
EPS:
10.48
Net Cash Flow:
$620.14M
1W Performance:
+1.81%
1M Performance:
-0.06%
6M Performance:
-5.91%
1Y Performance:
+20.31%
1-Day Range:
$345.88
$353.59
1-Week Range:
$342.79
$358.89
52-Week Range:
$279.24
$423.56
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
349.04 | 20.82B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
405.46 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.54 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
536.34 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
118.01 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
157.59 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-26-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Waters launches enhanced HPLC system with user authentication By Investing.com - Investing.com South Africa
Waters launches enhanced HPLC system with user authentication - Investing.com
Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity - PR Newswire
How Waters Co. (NYSE:WAT) Aligns With Evolving Scientific Trends in the S&P 500 Landscape? - Kalkine Media
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom - Investing.com
Here's Why Waters (WAT) is a Strong Growth Stock - Yahoo Finance
Waters (NYSE:WAT) Rating Lowered to Hold at Wall Street Zen - Defense World
Deutsche Bank Adjusts Price Target on Waters to $375 From $395 - marketscreener.com
Transcript : Waters Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08 - marketscreener.com
Waters sets a new benchmark for robustness and sensitivity for high-throughput labs with the Xevo TQ Absolute XR Mass Spectrometer - SelectScience
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer - Yahoo Finance
KeyBanc reiterates overweight rating on Waters Corp stock - Investing.com
KeyBanc reiterates overweight rating on Waters Corp stock By Investing.com - Investing.com UK
New Waters Mass Spectrometer Delivers Revolutionary 6X Performance Jump While Cutting Lab Costs in Half - Stock Titan
Waters Corporation (WAT) Announces Amendment to Credit Agreement - GuruFocus
Waters (NYSE:WAT) Downgraded by Wall Street Zen to “Hold” - Defense World
Why Waters (WAT) is a Top Growth Stock for the Long-Term - Yahoo Finance
Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality - marketscreener.com
Waters New Protein A Columns Cut Drug Development Time by 2 Days, Boost Sensitivity 7X - Stock Titan
Waters Corporation’s SWOT analysis: stock outlook amid biotech boom - Investing.com
Waters Corporation’s SWOT analysis: stock outlook amid biotech boom By Investing.com - Investing.com South Africa
Waters Corp (WAT) Stock Price Up 3.88% on May 27 - GuruFocus
Waters acquires Halo Labs, expanding biological analysis portfolio - SelectScience
Do Wall Street Analysts Like Waters Stock? - MSN
Waters Corporation (WAT) Announces Results of Annual Stockholders Meeting - GuruFocus
Waters Corp. acquires specialized imaging firm Halo Labs - Worcester Business Journal
Petri Dish: Thermo Fisher’s new partner; Waters buys California company - The Business Journals
Waters Corporation acquired Optofluidics, Inc. - marketscreener.com
Waters Acquires Halo Labs, Expands Biologic Analysis Portfolio - Contract Pharma
Waters Acquires Halo Labs - marketscreener.com
Waters (WAT) Enhances Capabilities with Acquisition of Halo Labs - GuruFocus
Waters (WAT) Enhances Capabilities with Acquisition of Halo Labs | WAT Stock News - GuruFocus
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio - PR Newswire
Waters Co. (NYSE:WAT) Stock Position Raised by Cetera Investment Advisers - Defense World
Waters (WAT) Sees Price Target Increase Amid Market Caution | WAT Stock News - GuruFocus
Ameriprise Financial Inc. Trims Stake in Waters Co. (NYSE:WAT) - Defense World
HSBC lifts Carnival Corp. rating as it is now ‘in calmer waters’ - Investing.com Australia
Waters Co. (NYSE:WAT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Waters Corp's India business boosted by rush for weight-loss drugs - MSN
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters CEO Brings Analytical Instruments Innovation to Jefferies Healthcare Conference 2025 - Stock Titan
Waters Sees Surge in India Demand as Drugmakers Race to Develop Weight-Loss Drug Generics - marketscreener.com
Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory CompliancePR Newswire APAC - PR Newswire Asia
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
What Makes Waters Corporation (WAT) a Lucrative Investment? - Yahoo Finance
3 Profitable Stocks in the Doghouse - FinancialContent
Waters (NYSE:WAT) Stock Unloaded Rep. Robert Bresnahan, Jr. - Defense World
Leerink Partnrs Has Negative Forecast for Waters Q3 Earnings - Defense World
Q2 Earnings Estimate for Waters Issued By Leerink Partnrs - Defense World
Waters (WAT) Stock Price Target Raised by Baird Analyst | WAT St - GuruFocus
Analyst Expectations For Waters's Future - Benzinga
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):